According to RAPT Therapeutics's latest financial reports the company has a price-to-book ratio of 1.92.
The price-to-book ratio is a way to measure how much the stock market thinks a company is worth compared to how much the company says its assets are worth on paper.
Year | P/B ratio | Change |
---|---|---|
2023-12-31 | 5.81 | 111.92% |
2022-12-31 | 2.74 | -52.89% |
2021-12-31 | 5.82 | 25.08% |
2020-12-31 | 4.66 | -43.53% |
2019-12-31 | 8.24 | |
2018-12-31 | N/A |
Company | P/B ratio | differencediff. | Country |
---|---|---|---|
ORIC Pharmaceuticals
ORIC | 2.86 | 48.95% | ๐บ๐ธ USA |